Kuros Biosciences (XSWX:KURN) Price-to-Operating-Cash-Flow : (As of Jun. 07, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Kuros Biosciences Price-to-Operating-Cash-Flow?

As of today (2024-06-07), Kuros Biosciences's share price is CHF9.12. Kuros Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-0.24. Hence, Kuros Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Kuros Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

XSWX:KURN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.46
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Kuros Biosciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was CHF-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-0.24.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 29.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 48.80% per year.

During the past 13 years, Kuros Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.10% per year. The lowest was -21.10% per year. And the median was 30.00% per year.

Kuros Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Kuros Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Price-to-Operating-Cash-Flow Chart

Kuros Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Kuros Biosciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Kuros Biosciences's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Kuros Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kuros Biosciences's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kuros Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kuros Biosciences's Price-to-Operating-Cash-Flow falls into.

Kuros Biosciences Price-to-Operating-Cash-Flow Calculation

Kuros Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9.12	/	-0.244
	=

Kuros Biosciences's Share Price of today is CHF9.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kuros Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-0.24.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Kuros Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences (XSWX:KURN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (XSWX:KURN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

CSBTF:USA KURNz:UK

Address

Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website

https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences (XSWX:KURN) Headlines

No Headlines